Behavioural and psychiatric symptoms in cognitive neurology

Neurología (English Edition) - Tập 32 - Trang 81-91 - 2017
A. Robles Bayón1, F. Gude Sampedro2
1Neurología cognitiva, Hospital La Rosaleda, Santiago de Compostela, La Coruña, Spain
2Unidad de Epidemiología Clínica, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, La Coruña, Spain

Tài liệu tham khảo

Moriarty, 2007, Psychiatric disorders in neurology patients, J Neurol Neurosurg Psychiatry, 78, 331, 10.1136/jnnp.2006.109058 Jefferies, 2007, Psychiatric disorders in inpatients on a neurology ward: estimate of prevalence and usefulness of screening questionnaires, J Neurol Neurosurg Psychiatry, 78, 414, 10.1136/jnnp.2006.103044 Schiffer, 1983, Psychiatric aspects of clinical neurology, Am J Psychiatry, 140, 205, 10.1176/ajp.140.2.205 Berlin, 1983, Psychiatric symptomatology in an outpatient neurology clinic, J Clin Psychiatry, 44, 204 Carson, 2000, Neurological disease, emotional disorder, and disability: they are related. A study of 300 consecutive new referrals to a neurology outpatient department, J Neurol Neurosurg Psychiatry, 68, 202, 10.1136/jnnp.68.2.202 Khoo, 2013, The impact of neuropsychiatric symptoms on caregiver distress and quality of life in persons with dementia in an Asian tertiary hospital memory clinic, Int Psychogeriatr, 25, 1991, 10.1017/S1041610213001518 Hurt, 2008, Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia, Dement Geriatr Cogn Disord, 26, 138, 10.1159/000149584 Shih, 2005, Psychiatric morbidity in dementia patients in a neurology-based memory clinic, Acta Neurol Taiwan, 14, 179 Proitsi, 2012, Association of serotonin and dopamine gene pathways with behavioral subphenotypes in dementia, Neurobiol Aging, 33, 791, 10.1016/j.neurobiolaging.2010.06.011 Flirski, 2012, PRND 3′UTR polymorphism may be associated with behavioral disturbances in Alzheimer disease, Prion, 6, 73, 10.4161/pri.6.1.18428 Hejl, 2003, Psychiatric morbidity in a neurology-based memory clinic: the effect of systematic psychiatric evaluation, J Am Geriatr Soc, 51, 1773, 10.1046/j.1532-5415.2003.51563.x Olivera, 2011, Detecting psychogeriatric problems in primary care: factors related to psychiatric symptoms in older community patients, Ment Health Fam Med, 8, 11 Altemus, 2014, Sex differences in anxiety and depression clinical perspectives, Front Neuroendocrinol, 35, 320, 10.1016/j.yfrne.2014.05.004 Donner, 2013, Sex differences in anxiety and emotional behavior, Pflugers Arch, 465, 601, 10.1007/s00424-013-1271-7 Brendel, 2005, Psychotic symptoms in the elderly, Prim Care Companion J Clin Psychiatry, 7, 238, 10.4088/PCC.v07n0506 Flint, 1997, Epidemiology and comorbidity of anxiety disorders in later life: implications for treatment, Clin Neurosci, 4, 31 Viertiö, 2007, Visual impairment in persons with psychotic disorder, Soc Psychiatry Psychiatr Epidemiol, 42, 902, 10.1007/s00127-007-0252-6 Ballard, 1995, Associations of psychotic symptoms in dementia sufferers, Br J Psychiatry, 167, 537, 10.1192/bjp.167.4.537 Ballard, 2000, Anxiety, depression and psychosis in vascular dementia: prevalence and associations, J Affect Disord, 59, 97, 10.1016/S0165-0327(99)00057-9 Ostling, 2011, Psychotic symptoms in a population-based sample of 85-year-old individuals with dementia, J Geriatr Psychiatry Neurol, 24, 3, 10.1177/0891988710373596 Sweet, 2003, Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype, Mol Psychiatry, 8, 383, 10.1038/sj.mp.4001262 Virués-Ortega, 2008, Funcionamiento neuropsicológico bajo condiciones de hipoxia aguda y crónica asociada a la altitud, Arch Biol Andina, 14, 40 Richter, 2005, The pathophysiology of emotional lability: many paths to a common destination, Am J Geriatr Pharmacother, 3, 9, 10.1016/S1543-5946(05)80032-7 Wei, 2004, Glucocorticoid receptor overexpression in forebrain: a mouse model of increased emotional lability, Proc Natl Acad Sci U S A, 101, 11851, 10.1073/pnas.0402208101 Banno, 2014, Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease, Neuropsychiatr Dis Treat, 10, 339 Senanarong, 2004, Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction, Dement Geriatr Cogn Disord, 17, 14, 10.1159/000074080 Starkstein, 1997, Mechanism of disinhibition after brain lesions, J Nerv Ment Dis, 185, 108, 10.1097/00005053-199702000-00007 Ames, 1994, Repetitive and compulsive behavior in frontal lobe degenerations, J Neuropsychiatry Clin Neurosci, 6, 100, 10.1176/jnp.6.2.100 Muehlmann, 2012, Abnormal repetitive behaviours: shared phenomenology and pathophysiology, J Intellect Disabil Res, 56, 427, 10.1111/j.1365-2788.2011.01519.x Whitwell, 2007, VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration, Neuroimage, 35, 207, 10.1016/j.neuroimage.2006.12.006 Uher, 2005, Brain lesions and eating disorders, J Neurol Neurosurg Psychiatry, 76, 852, 10.1136/jnnp.2004.048819 Suda, 2010, Dieting tendency and eating behavior problems in eating disorder correlate with right frontotemporal and left orbitofrontal cortex: a near-infrared spectroscopy study, J Psychiatr Res, 44, 547, 10.1016/j.jpsychires.2009.11.005 Mena, 2011, Induction of hyperphagia and carbohydrate intake by μ-opioid receptor stimulation in circumscribed regions of frontal cortex, J Neurosci, 31, 3249, 10.1523/JNEUROSCI.2050-10.2011 Hoffmann, 2008, Isolated right temporal lobe stroke patients present with Geschwind Gastaut syndrome, frontal network syndrome and delusional misidentification syndromes, Behav Neurol, 20, 83, 10.1155/2008/847685 Hudson, 2000, Misidentification syndromes related to face specific area in the fusiform gyrus, J Neurol Neurosurg Psychiatry, 69, 645, 10.1136/jnnp.69.5.645 Hein, 2014, Impact of polypharmacy on occurrence of delirium in elderly emergency patients, J Am Med Dir Assoc, 15, 850, 10.1016/j.jamda.2014.08.012 Hogan, 1997, Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients, CMAJ, 157, 1071 Andrade, 2009, Safety and efficacy of antipsychotic drugs for the behavioral and psychological symptoms of dementia, Indian J Psychiatry, 51, S87 Angelini, 2007, Behavioral and psychological symptoms of dementia (BPSD) in elderly demented subjects: is the long lasting use of atypical antipsychotic drugs useful and safe?, Arch Gerontol Geriatr, 44, 35, 10.1016/j.archger.2007.01.005 Sarazin, 2003, Metabolic correlates of behavioral and affective disturbances in frontal lobe pathologies, J Neurol, 250, 827, 10.1007/s00415-003-1087-z Mateen, 2009, The clinical spectrum of stereotypies in frontotemporal lobar degeneration, Mov Disord, 24, 1237, 10.1002/mds.22555 Ecker, 2009, Dopamine agonists and their risk to induce psychotic episodes in Parkinson's disease: a case–control study, BMC Neurol, 9, 23, 10.1186/1471-2377-9-23 Friedman, 1991, Psychotic complications of long-term levodopa treatment of Parkinson's disease, Acta Neurol Scand, 84, 111, 10.1111/j.1600-0404.1991.tb04918.x Onofrj, 2013, Visual hallucinations in PD and Lewy body dementias: old and new hypotheses, Behav Neurol, 27, 479, 10.1155/2013/703924 Bertram, 2012, Visual hallucinations in the differential diagnosis of parkinsonism, J Neurol Neurosurg Psychiatry, 83, 448, 10.1136/jnnp-2011-300980 Rabey, 2009, Hallucinations and psychosis in Parkinson's disease, Parkinsonism Relat Disord, 15, S105, 10.1016/S1353-8020(09)70846-6 Burghaus, 2012, Hallucinations in neurodegenerative diseases, CNS Neurosci Ther, 18, 149, 10.1111/j.1755-5949.2011.00247.x Di Santo, 2013, A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease, J Alzheimers Dis, 35, 349, 10.3233/JAD-122140 Rolinski, 2012, Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease, Cochrane Database Syst Rev, 3, CD006504 Lutz, 2013, Opioid receptors: distinct roles in mood disorders, Trends Neurosci, 36, 195, 10.1016/j.tins.2012.11.002 Zabalza-Estévez, 2014, Alucinaciones musicales: la música perpetua, Rev Neurol, 58, 207 Gilbert, 1993, Pentoxifylline-induced musical hallucinations, Neurology, 43, 1621, 10.1212/WNL.43.8.1621 Pitner, 1993, Pentoxifylline (Trental)-induced visual hallucinations, J Am Geriatr Soc, 41, 782, 10.1111/j.1532-5415.1993.tb07477.x 2009, Trimetazidine: abnormal movements and hallucinations. Should be withdrawn from the market, Prescrire Int, 18, 69 Alonso-Navarro, 2006, Alucinaciones inducidas por flunaricina, Rev Neurol, 42, 315 Rosenthal, 1987, Visual hallucinations and suicidal ideation attributed to isosorbide dinitrate, Psychosomatics, 28, 555, 10.1016/S0033-3182(87)72471-2 O’Brien, 2003, Behavioral symptoms in vascular cognitive impairment and vascular dementia, Int Psychogeriatr, 15, 133, 10.1017/S1041610203009098 Staekenborg, 2010, Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease, J Neurol Neurosurg Psychiatry, 81, 547, 10.1136/jnnp.2009.187500 Bandyopadhyay, 2014, Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia, Ann Indian Acad Neurol, 17, 325, 10.4103/0972-2327.138520 Tatley, 2007, Psychiatric adverse reactions with statins, fibrates and ezetimibe: implications for the use of lipid-lowering agents, Drug Saf, 30, 195, 10.2165/00002018-200730030-00003 You, 2013, The relationship between statins and depression: a review of the literature, Expert Opin Pharmacother, 14, 1467, 10.1517/14656566.2013.803067 Tuccori, 2014, Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management, CNS Drugs, 28, 249, 10.1007/s40263-013-0135-1 Macedo, 2014, Unintended effects of statins from observational studies in the general population: systematic review and meta-analysis, BMC Med, 12, 51, 10.1186/1741-7015-12-51 Parsaik, 2014, Statins use and risk of depression: a systematic review and meta-analysis, J Affect Disord, 160, 62, 10.1016/j.jad.2013.11.026 O’Neil, 2012, The impact of statins on psychological wellbeing: a systematic review and meta-analysis, BMC Med, 10, 154, 10.1186/1741-7015-10-154 Feng, 2008, Association between depressive symptoms and use of HMG-CoA reductase inhibitors (statins), corticosteroids and histamine H(2) receptor antagonists in community-dwelling older persons: cross-sectional analysis of a population-based cohort, Drugs Aging, 25, 795, 10.2165/00002512-200825090-00005 Passare, 2004, Sodium and potassium disturbances in the elderly: prevalence and association with drug use, Clin Drug Investig, 24, 535, 10.2165/00044011-200424090-00004